Dailybacs® Kids

One pack of Dailybacs® Kids contains 30 sachets. This corresponds to a 30-day supply.

Only the probiotic bacterial strains that have been studied in the most studies and have shown the best effectiveness are included in our products.

10 bacterial strains – 4 billion colony forming units (CFUs) per sachet:

1. bacterial strains
2. Bifidobacterium breve BR03
3. Lactobacillus plantarum LP01
4. Bifidobacterium animalis subsp. lactis BS01
5. Lactobacillus rhamnosus LR06
6. Bifidobacterium infantis BI02
7. Lactobacillus paracasei LPC00
8. Lactobacillus rhamnosus GG
9. Bifidobacterium longum 04
10. Lactobacillus rhamnosus LR04
11. Lactobacillus reuteri LRE02

Playfully easy: We recommend 1x sachet Dailybacs® Kids daily before breakfast However, the preparation can also be taken at any other time without any problem – but at the latest before the last brushing of the teeth.

Simply open the sachet and let the contents dissolve directly on the tongue. Thanks to the delicious taste and fast dissolving, taking the capsules becomes a child-friendly experience. No water, no swallowing capsules – simple, convenient, and effective.

Recommended age
Dailybacs® Kids are suitable for children ages 3-17. Our formula was specifically developed to meet children's preferences and is free of artificial additives or allergens. We recommend switching to Dailybacs® Female/Male at age 17. Due to the higher dosage, a short-term worsening of symptoms may occur during the transition.

no

Promoting intestinal balance

Keikha, M., & Karbalaei, M. (2021). Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections. BMC Gastroenterology, 21(1).

Solito, A., Hasballa, I., Calgaro, M., Bozzi, CN, Ricotti, R., Caputo, M., Genoni, G., Monzani, A., Archero, F., Bellone, S., Bona, G., Agosti, E., Aimaretti, G., Amoruso, A., Pane, M., Vitulo, N., Di, GD, & Prodam, F (2020). Supplementation with Bifidobacterium breve BR03 and Bifidobacterium breve B632 favored weight loss and improved insulin metabolism in children and adolescents with obesity in the BIFI-OBESE cross-over, randomized placebo-controlled trial. Endocrine Abstracts.

Drago, L., Meroni, G., Chiaretti, A., Laforgia, N., Cucchiara, S., & Baldassarre, M. (2020). Effect of Limosilactobacillus reuteri LRE02–lacticaseibacillus rhamnosus LR04 combination on antibiotic-associated diarrhea in a pediatric population: A national survey. Journal of Clinical Medicine, 9(10), 3080.

Chamignon, C., Guéneau, V., Medina, S., Deschamps, J., Gil-Izquierdo, A., Briandet, R., Mousset, P., Langella, P., Lafay, S., & Bermúdez-Humarán, LG (2020). Evaluation of the probiotic properties and the capacity to form biofilms of various lactobacillus strains. Microorganisms, 8(7), 1053.

Kara, S., Volkan, B., & Erten, I. (2019). Lactobacillus rhamnosusGG can protect malnourished children. Beneficial Microbes, 10(3), 237-244.

The Effect of Lactobacillus GG (LGG) on Acute Diarrheal Illness in the Pediatric Emergency Department (PED)

Lam, EK, Tai, EK, Koo, MW, Wong, HP, Wu, WK, Yu, L., So, WH, Woo, PC, & Cho, C. (2007). Enhancement of gastric mucosal integrity by lactobacillus rhamnosus GG. Life Sciences, 80(23), 2128-2136.

Mack, D.R. (2003). Extracellular MUC3 mucin secretion follows adherence of lactobacillus strains to intestinal epithelial cells in vitro. Good, 52(6), 827-833.

Strengthening the immune system

Approach to probiotics in pediatrics: The role of lactobacillus rhamnosus GG. (2022). Archivos Argentinos de Pediatria, 120(1).

Keikha, M., & Karbalaei, M. (2021). Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections. BMC Gastroenterology, 21(1

Ferrari, E., Monzani, R., Saverio, V., Gagliardi, M., Pańczyszyn, E., Raia, V., Villella, VR, Bona, G., Pane, M., Amoruso, A., & Corazzari, M. (2021). Probiotics supplements reduce ER stress and gut inflammation associated with gliadin intake in a mouse model of gluten sensitivity. Nutrients, 13(4), 1221.

Primec, M., Klemenak, M., Di Gioia, D., Aloisio, I., Bozzi Cionci, N., Quagliariello, A., Gorenjak, M., Mičetić-Turk, D., & Langerholc, T. (2019). Clinical intervention using Bifidobacterium strains in celiac disease children reveals novel microbial modulators of TNF-α and short-chain fatty acids. Clinical Nutrition, 38(3), 1373-1381.

Quagliariello, A., Aloisio, I., Bozzi Cionci, N., Luiselli, D., D'Auria, G., Martinez-Priego, L., Pérez-Villarroya, D., Langerholc, T., Primec, M., Mičetić-Turk, D., & Di Gioia, D. (2016). Effect of Bifidobacterium breve on the intestinal microbiota of celiac children on a gluten-free diet: A pilot study. Nutrients, 8(10), 660.

Klemenak, M., Dolinšek, J., Langerholc, T., Di Gioia, D., & Mičetić-Turk, D. (2015). Administration of Bifidobacterium breve decreases the production of TNF-α in children with celiac disease. Digestive Diseases and Sciences, 60(11), 3386-3392.

Berni Canani, R., Di Costanzo, M., Pezzella, V., Cosenza, L., Granata, V., Terrin, G., & Nocerino, R. (2012). The potential therapeutic efficacy of lactobacillus GG in children with food allergies. Pharmaceuticals, 5(6), 655-664.

Promote cognitive development

Sanborn, V., Azcarate-Peril, MA, Updegraff, J., Manderino, LM, & Gunstad, J. (2018). A randomized clinical trial examining the impact of LGG probiotic supplementation on psychological status in middle-aged and older adults. Contemporary Clinical Trials Communications, 12, 192-197.

Mood regulation

Kumperscak, HG, Gricar, A., Ülen, I., & Micetic-Turk, D. (2020). A pilot randomized control trial with the probiotic strain lactobacillus rhamnosus GG (LGG) in ADHD: Children and adolescents report better health-related quality of life. Frontiers in Psychiatry,